We are live on ! Find out more
CI

Cambiar Investors Portfolio holdings

AUM $2.3B
1-Year Est. Return 24.77%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+24.77%
3 Year Est. Return
+59.19%
5 Year Est. Return
+64.5%
10 Year Est. Return
+13,161.1%
AUM
$2.37B
AUM Growth
+$46.3M
Cap. Flow
-$66.1M
Cap. Flow %
-2.79%
Top 10 Hldgs %
22.2%
Holding
154
New
14
Increased
50
Reduced
77
Closed
11

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$42.9M
2
COP icon
ConocoPhillips
COP
+$30.3M
3
CME icon
CME Group
CME
+$25.7M
4
TXN icon
Texas Instruments
TXN
+$24M
5
TEL icon
TE Connectivity
TEL
+$13.9M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$36.3M
2
OKE icon
Oneok
OKE
+$30.7M
3
WELL icon
Welltower
WELL
+$29.6M
4
HUM icon
Humana
HUM
+$28.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$18.7M

Sector Composition

Rank Sector Weight
1 Financials 18.09%
2 Technology 15.66%
3 Healthcare 15.52%
4 Industrials 15.33%
5 Energy 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVA icon
126
Avista
AVA
$3.24B
$1.83M 0.08%
46,513
-5,747
-11% -$244K
ENV
127
DELISTED
ENVESTNET, INC.
ENV
$1.81M 0.08%
30,429
-15,793
-34% -$915K
MAN icon
128
ManpowerGroup
MAN
$2.63B
$1.8M 0.08%
22,725
-2,895
-11% -$218K
PB icon
129
Prosperity Bancshares
PB
$8.89B
$1.73M 0.07%
30,651
-1,467
-5% -$87.6K
UBSI icon
130
United Bankshares
UBSI
$6.62B
$1.73M 0.07%
58,244
-724
-1% -$22.8K
NUVA
131
DELISTED
NuVasive, Inc.
NUVA
$1.72M 0.07%
41,348
-5,531
-12% -$227K
CRNC icon
132
Cerence
CRNC
$413M
$1.7M 0.07%
58,004
-7,906
-12% -$217K
FORR icon
133
Forrester Research
FORR
$224M
$1.67M 0.07%
57,270
-6,769
-11% -$201K
IJH icon
134
iShares Core S&P Mid-Cap ETF
IJH
$127B
$1.55M 0.07%
29,615
-6,310
-18% -$314K
JRVR icon
135
James River Group Holdings
JRVR
$217M
$1.53M 0.06%
83,636
-10,727
-11% -$214K
AGG icon
136
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.38M 0.06%
14,051
TTE icon
137
TotalEnergies
TTE
$190B
$888K 0.04%
15,400
-3
-0% -$182
WELL icon
138
Welltower
WELL
$171B
$351K 0.01%
4,334
-384,451
-99% -$29.6M
FISV
139
Fiserv Inc
FISV
$27.9B
$247K 0.01%
1,959
-308,432
-99% -$36.3M
VSAT icon
140
Viasat
VSAT
$11.1B
$206K 0.01%
4,986
-1,203
-19% -$46.8K
DXYN
141
DELISTED
Dixie Group Inc
DXYN
$66.6K ﹤0.01%
50,089
+4,173
+9% +$4.02K
DALN
142
DELISTED
DallasNews
DALN
$43.7K ﹤0.01%
+11,238
New +$46.1K
PW
143
Power REIT
PW
$2.84M
$17.9K ﹤0.01%
+1,089
New +$26.1K
ACWI icon
144
iShares MSCI ACWI ETF
ACWI
$33.4B
-7,596
Closed -$692K
AMED
145
DELISTED
Amedisys
AMED
-89,982
Closed -$6.62M
HAIN icon
146
Hain Celestial
HAIN
$53.7M
-82,691
Closed -$1.42M
HUBB icon
147
Hubbell
HUBB
$27.2B
-36,974
Closed -$9M
HUM icon
148
Humana
HUM
$46.2B
-58,633
Closed -$28.5M
ICUI icon
149
ICU Medical
ICUI
$4.61B
-11,756
Closed -$1.94M
KOF icon
150
Coca-Cola Femsa
KOF
$23.2B
-11,210
Closed -$902K

Similar funds

Cambiar Investors's Q2 2023 Portfolio in Review

As of Q2 2023, Cambiar Investors held 154 positions worth $2.37B, up 2% from $2.32B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cambiar Investors's Q2 2023 filing shows 14 new, 50 increased, 77 reduced and 11 closed positions. Its largest new stake was Bristol-Myers Squibb: 639,251 shares worth $40.9M. The largest sale was Fiserv Inc, an estimated $36.3M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Cambiar Investors's largest Q2 2023 buy was Bristol-Myers Squibb: 639,251 shares worth $40.9M.
  • Cambiar Investors added most to TE Connectivity in Q2 2023, an estimated $13.9M increase.
  • Cambiar Investors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $36.3M.
  • Cambiar Investors fully exited Oneok in Q2 2023, selling an estimated $30.7M.
  • Cambiar Investors's ten largest holdings make up 22% of its $2.37B portfolio in Q2 2023.
  • Cambiar Investors opened 14 new positions and closed 11 in Q2 2023.
  • Cambiar Investors's portfolio value rose 2% quarter-over-quarter to $2.37B.

Based on Cambiar Investors's 13F filing for Q2 2023, filed 31 Jul 2023.